FDA authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID19 to include children 5 through 11 years of age.  Key points: Effectiveness: Immune responses of children 5 through 11 years of age were comparable to those of individuals 16 through 25 years of age. In addition, t...

Association between COVID-19 and Myocarditis Using Hospital-Based Administrative Data — United States, March 2020–January 2021 Viral infections are a common cause of myocarditis, an inflammation of the heart muscle (myocardium) that can result in hospitalization, heart failure, and sudden death. Emerging data suggest an association between...

Food and Drug Administration advisory committee (US FDA) unanimously recommend the third shots to people age 65 and older and those at a high risk of suffering from severe illness if they get the coronavirus. Rejected a proposal to distribute booster/third shots of Pfizer and BioNTech’s Covid-19 vaccine to the General Public. RemoveA...

 Having a comprehensive understanding of the transmission patterns of SARS-CoV-2 is necessary for the successful implementation of these public health measures.For example, obtaining information about when individuals with SARS-CoV-2 are most likely to spread the virus may guide decisions about the duration of contact tracing an...

Patients with asthma were considered to be at elevated risk early in the COVID-19 pandemic. The study showed that physical activity was less in patients with asthma. However, the groups had similar fear, perceived stress, and quality of life. Total physical activity level, vigorous physical activity level, and walking score of patients wit...